BridgeBio Pharma Inc — Quarterly Financial Statistics (NASDAQ:BBIO) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -195.33 M-199.24 M-80.68 M-109.57 M-56.42 M -445.91 M Cash from investing activities -3.24 M-1.59 M-13 M4.46 M-14.35 M -24.49 M Cash from financing activities 473.93 M60.33 M302.04 M-894 K-2.18 M 359.29 M Free cash flow -198.56 M-200.83 M-85.78 M-112.44 M-56.45 M -455.5 M

뉴스

TechnipFMC Defies Market, Hits Record High, Leads 16 Top Performers To IBD Best Stock Lists

Oil Major EQT Pops To Record High, Leads 23 Hot Names New To Best Stock Lists

Tracking Ole Andreas Halvorsen’s Viking Global Portfolio – Q4 2025 Update

Can Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead?

Monday’s insider activity: Vail Resorts CEO buys $4.9 million

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors

린킨 파트너스, 브리지바이오에 ’아웃퍼폼’ 투자의견 유지, 목표가 98달러

Leerink Partners reiterates Outperform on BridgeBio stock at $98

BridgeBio Pharma, Inc. (BBIO) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

BridgeBio, LGMD2I/R9 치료제 긍정적 중간 데이터 발표

BridgeBio presents positive interim data for LGMD2I/R9 therapy

JPMorgan adds BridgeBio to focus list, lifts target to $94